Vivex Biologics Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
228
- Latest Deal Type
-
Sale-Lease back
- Financing Rounds
-
7
- Investments
-
2
Vivex Biologics General Information
Description
Operator of a research-driven biologic firm intended to create new standards in patient care. The company's focus lies on creating treatment options and creative services to advance clinical, surgical and therapeutic patient care by expanding industry knowledge and capability, enabling the clients of medical and material science industries, to meet their needs, as per the diverse and rapidly growing market.
Contact Information
Website
www.vivex.comCorporate Office
- 2430 Northwest 116th Street
- Suite 200
- Miami, FL 33167
- United States
Corporate Office
- 2430 Northwest 116th Street
- Suite 200
- Miami, FL 33167
- United States
Vivex Biologics Timeline
Vivex Biologics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Vivex Biologics Comparisons
Industry
Financing
Details
Vivex Biologics Competitors (15)
One of Vivex Biologics’s 15 competitors is Kymera Therapeutics, a Formerly VC-backed company based in Watertown, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Kymera Therapeutics | Formerly VC-backed | Watertown, MA | ||||
| InterAx | Venture Capital-Backed | Schlieren, Switzerland | ||||
| Lisata Therapeutics | Corporation | Basking Ridge, NJ | ||||
| Humacyte | Formerly VC-backed | Durham, NC | ||||
| Capricor Therapeutics | Formerly VC-backed | San Diego, CA |
Vivex Biologics Patents
Vivex Biologics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-D911547-S1 | Mixing container | Active | 08-Aug-2019 | ||
| US-20150351889-A1 | Dynamic biometric mesh | Inactive | 05-Jun-2014 | ||
| WO-2015066732-A2 | Spinal tissue composition | Inactive | 31-Oct-2013 | ||
| WO-2015066732-A3 | Spinal tissue composition | Inactive | 31-Oct-2013 | ||
| WO-2014123699-A1 | Bone growth enhancing implant | Inactive | 11-Feb-2013 | A61L27/50 |
Vivex Biologics Signals
Vivex Biologics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Vivex Biologics Investments & Acquisitions (2)
Vivex Biologics’s most recent deal was a Accelerator/Incubator with QuarkXR. The deal was made on 28-Mar-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| QuarkXR | 28-Mar-2018 | Accelerator/Incubator | Business/Productivity Software | ||
| University of Miami Tissue Bank (Certain assets and Agreements) | 18-Nov-2014 | Merger/Acquisition | Other Healthcare Services |
Vivex Biologics FAQs
-
When was Vivex Biologics founded?
Vivex Biologics was founded in 2012.
-
Where is Vivex Biologics headquartered?
Vivex Biologics is headquartered in Miami, FL.
-
What is the size of Vivex Biologics?
Vivex Biologics has 228 total employees.
-
What industry is Vivex Biologics in?
Vivex Biologics’s primary industry is Drug Discovery.
-
Is Vivex Biologics a private or public company?
Vivex Biologics is a Private company.
-
What is Vivex Biologics’s current revenue?
The current revenue for Vivex Biologics is .
-
How much funding has Vivex Biologics raised over time?
Vivex Biologics has raised $42.5M.
-
Who are Vivex Biologics’s investors?
Ellis Capital and JAM Capital Partners have invested in Vivex Biologics.
-
Who are Vivex Biologics’s competitors?
Kymera Therapeutics, InterAx, Lisata Therapeutics, Humacyte, and Capricor Therapeutics are some of the 15 competitors of Vivex Biologics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process